Subscribe to MDT Magazine News

AngioSculpt "EX" PTCA Scoring Balloon Catheter by AngioScore, Inc.: Recall - Risk of Catheter Separation

September 8, 2010 1:30 pm | by U.S. Food & Drug Administration | Comments

Fragments of the catheter may become lodged in coronary arteries, resulting in serious injury or death.


Nursing home co. settles $677M lawsuit for $50M

September 8, 2010 12:45 pm | by The Associated Press | Comments

A California nursing home company has agreed to pay $50 million to settle a lawsuit that resulted in a $677 million jury award in favor of thousands of current and former patients.Orange County-based Skilled Healthcare Group Inc. announced the settlement late Tuesday. The money will go to the...

NVCA launches MedIC life sciences coalition

September 8, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | Comments

The National Venture Capital Association, its member venture capital firms and life sciences companies are teaming up to form the Medical Innovation and Competitiveness (MedIC) Coalition, which will advocate for policies and regulations that advance medical innovation in the U.S.


Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser

September 8, 2010 7:32 am | by Bio-Medicine.Org | Comments

ATLANTA, Sept. 8 /- Elekta is one of the leading supporters of the Rocks Against Cancer benefit to take place September 16 at the Angel Orensanz Foundation for the Arts in New York City. Proceeds from the event will support EIF cancer programs, including Stand Up to Cancer (SU2C), an...


NEXUS Biosystems Completes Acquisition of REMP Sample Management Business From Tecan Group

September 8, 2010 7:31 am | by Bio-Medicine.Org | Comments

POWAY, Calif., Sept. 8 /- NEXUS Biosystems, Inc., a leading innovator and worldwide provider of automated sample management systems, today announced the completion of the acquisition of REMP AG of Switzerland, a wholly-owned subsidiary of the Tecan Group.   NEXUS announced on July...


Misonix Announces New Distribution Agreement for France

September 8, 2010 6:32 am | by Bio-Medicine.Org | Comments

FARMINGDALE, N.Y., Sept. 8 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Cormedica s.a.s.  Based...


Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology

September 8, 2010 6:31 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Sept. 7 /- GE Healthcare announced today that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology . Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by...


Researchers Explore Use for Head, Neck, Prostate, Breast and Lung Tumors, as Well as More Complex Blood Cancer and Mesothelioma Treatments

September 8, 2010 5:45 am | by The Associated Press | Comments

TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, today announced that 82 studies examining the use of the TomoTherapy@ treatment system to treat common, complex and rare tumors...


electronica 2010 ? electronics industry demonstrates its future viability

September 8, 2010 5:33 am | by I-Micronews | Comments

electronica will present the future of the electronics industry at the New Munich Trade Fair Center from November 9 to 12, 2010.

Cardiorobotics collects $500K of planned $5M round

September 8, 2010 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Less than one year after raising a $5 million funding round, Cardiorobotics Inc. has started another $5 million round with a $500,000 tranche.

Diabetes-focused biotech Rhythm closes $40M Series A round

September 8, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Rhythm Pharmaceuticals Inc., a startup focused on obesity and diabetes treatments, had closed a $40 million Series A financing, funded by MPM Capital and Third Rock Ventures, both of Boston, as well as New Enterprise Associates of Maryland.

Streamline Health Document Workflow Solutions Purchased By Tampa, Florida-Based Hospital

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

CINCINNATI, Sept. 8 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of...


STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., Sept. 8 /- STAAR Surgical Company (Nasdaq: STAA ), the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by...


MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Sept. 8 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed...


Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Sept. 8 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' 2010 Healthcare Conference on Thursday, September 16, 2010 at 8:35 a.m. ET at The Four Seasons...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.